The rate constant of the reaction of bromine atoms with molecular fluorine is determined by mass spectrometrically monitoring BrF produced at fixed reaction time as a function of the concentration of F2 added to a flowing mixture of Br and Br2 in He diluent. The rate constant is 1.31×10−13 exp(−17.9 kJ mole−1/RT) cm3 molecule−1 sec−1 over the temperature range 296–418° K. Br+F2 is thus another example of the anomalously slow rate which is characteristic of the reactions of F2 with many atoms.
Chemical accelerator studies on isotopic variants of the reaction Ar+ + CH. --I ArH+ + CH 3 are reported. Velocity and angular distributions of the ionic product as a function of initial translational energy have been measured over the energy range 0.39-25 eV center-of-mass (c.m.). The asymmetry of the product distribution with respect to the center of mass indicates that the reaction is predominantly direct over the energy range studied. The dynamics of the reaction are approximated by the spectator stripping model: The reaction exothermicity appears as product internal energy and product excitation increases with collision energy at the rate predicted by this model. The internal degrees of freedom of the neutral product have little effect on reaction dynamics, and product excitation appears to reside principally in the ionic product. Deviations from the spectator stripping model suggest the existence of a basin in the potential energy hypersurface for this reaction; the ArCH: complex which may be formed at low collision energies, however. preferentially decomposes via reaction channels other than that resulting in ArH+ formation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.